Motu Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Motu Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services

Secondary Activities: Pharmaceutical Preparation Manufacturing | Machinery, Equipment, and Supplies Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Outpatient Care Centers | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals | Hair, Nail, and Skin Care Services

Full name: Motu Sp. z o.o.

Profile Updated: November 01, 2023

Motu Sp. z o.o. is an enterprise in Poland, with the main office in Krakow. The company operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on March 09, 2018.

Headquarters
Ul. Swietokrzyska 4/3
Krakow; Malopolskie; Postal Code: 30-015

Contact Details: Purchase the Motu Sp. z o.o. report to view the information.

Basic Information

Outstanding Shares:

Purchase the Motu Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Motu Sp. z o.o. report to view the information.

Incorporation Date:

March 09, 2018

Key Executives

Purchase this report to view the information.

Management Board Member

Purchase this report to view the information.

Management Board Member

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Motu Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating profit (EBIT)

-208.41%▼

Net Profit (Loss) for the Period

-208.41%▼

Total equity

-17.16%▼

Return on Equity (ROE)

9.08%▲